食管切除或胃切除术后良性吻合口狭窄的内镜下切开治疗:系统综述与Meta分析
该系统综述与Meta分析评估内镜下切开治疗(EIT)用于食管切除或胃切除术后良性吻合口狭窄的疗效,共纳入5项研究。结果显示,与扩张相比,EIT可降低总体狭窄复发风险(OR 0.35)及初治狭窄复发风险(OR 0.32),但在复发性狭窄中无显著差异(OR 0.63)。无狭窄持续时间显著延长(MD 42.76)。
要点
- 与扩张相比,EIT降低总体吻合口狭窄复发风险(OR 0.35,95%CI 0.13-0.92)。
- 初治狭窄中EIT降低复发风险(OR 0.32,95%CI 0.17-0.59),复发性狭窄中无显著差异。
- EIT组无狭窄持续时间较扩张组显著延长(MD 42.76,95%CI 12.41-73.11)。
核心结论
- 当前数据提示,EIT与初治吻合口狭窄的复发风险降低相关。
- 需要大型前瞻性研究来明确EIT的安全性、处理发表偏倚并探索难治性狭窄的多模式治疗。
研究设计与样本
- 系统综述与Meta分析,检索数据库截至2023年4月2日。
- 纳入标准:接受EIT治疗食管切除或胃切除术后良性吻合口狭窄的人类受试者,年龄≥18岁,样本量n≥5。
- 共筛选2550篇初检研究,33篇全文审查,最终5项研究符合纳入标准。
- Meta分析使用RevMan 5.4.1,采用Mantel-Haenszel随机效应模型。
- 发表偏倚通过漏斗图和Egger检验评估。
主要发现
- 与扩张相比,EIT组总体狭窄复发风险降低(OR 0.35,95%CI 0.13-0.92,p=0.03;I²=71%)。
- 初治狭窄中,EIT组复发风险低于扩张组(OR 0.32,95%CI 0.17-0.59,p=0.0003;I²=0%)。
- 复发性狭窄中,EIT组与扩张组复发风险无显著差异(OR 0.63,95%CI 0.12-3.28,p=0.58;I²=81%)。
- EIT组无狭窄持续时间较扩张组显著延长(MD 42.76,95%CI 12.41-73.11,p=0.006)。
关键数值与推荐
- 总体狭窄复发:EIT组 vs 扩张组 OR 0.35(95%CI 0.13-0.92,p=0.03;I²=71%)。
- 初治狭窄复发:EIT组 vs 扩张组 OR 0.32(95%CI 0.17-0.59,p=0.0003;I²=0%)。
- 复发性狭窄复发:EIT组 vs 扩张组 OR 0.63(95%CI 0.12-3.28,p=0.58;I²=81%)。
- 无狭窄持续时间:EIT组 vs 扩张组 MD 42.76(95%CI 12.41-73.11,p=0.006)。
临床怎么用
- 原文未据此给出推荐。
局限性
- Meta分析显示总体狭窄复发分析存在异质性(I²=71%),复发性狭窄分析存在异质性(I²=81%)。
- 原始研究未报告EIT的安全性特征,需大型前瞻性研究来明确。
- 存在发表偏倚可能,需进一步处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Studies have evaluated the efficacy of endoscopic incisional therapy (EIT) for benign anastomotic strictures. We performed a systematic review and meta-analysis to evaluate stricture recurrence after EIT following esophagectomy or gastrectomy. METHODS: A systematic search of databases was performed up to April 2nd, 2023, after selection of key search terms with the research team. Inclusion criteria included human participants undergoing EIT for a benign anastomotic stricture after esophagectomy or gastrectomy, age ≥ 18, and n ≥ 5. Our primary outcome was the incidence of stricture recurrence among patients treated with EIT compared to dilation. Our secondary outcome was the stricture-free duration after EIT and rate of adverse events. Meta-analysis was performed with RevMan 5.4.1 using a Mantel-Haenszel random-effects model. Publication bias was evaluated with funnel plots and the Egger test. RESULTS: A total of 2550 unique preliminary studies underwent screening of abstracts and titles. This led to 33 studies which underwent full-text review and five studies met the inclusion criteria. Meta-analysis revealed reduced odds of overall stricture recurrence (OR 0.35, 95% CI 0.13-0.92, p = 0.03; I2 = 71%) and reduced odds of stricture recurrence among naïve strictures (OR 0.32, 95% CI 0.17-0.59, p = 0.0003; I2 = 0%) for patients undergoing EIT compared to dilation. There was no significant difference in the odds of stricture recurrence among recurrent strictures (OR 0.63, 95% CI 0.12-3.28, p = 0.58; I2 = 81%). Meta-analysis revealed a significant increase in the recurrence-free duration (MD 42.76, 95% CI 12.41-73.11, p = 0.006) among patients undergoing EIT compared to dilation. CONCLUSION: Current data suggest EIT is associated with reduced odds of stricture recurrence among naïve anastomotic strictures. Large, prospective studies are needed to characterize the safety profile of EIT, address publication bias, and to explore multimodal therapies for refractory strictures.
引用
- Jimoh Z, Jogiat U, Hajjar A, et al. Endoscopic incisional therapy for benign anastomotic strictures after esophagectomy or gastrectomy: a systematic review and meta-analysis. Surg Endosc. 2024. PMID: 38649492. doi:10.1007/s00464-024-10817-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。